MoneyWorks4Me

Shilpa Medicare informs about credit rating

28 Mar 2023 Evaluate
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Regulation'), Shilpa Medicare has informed that India Ratings & Research (Ind-Ra) has issued Long-Term Issuer Rating at 'IND A'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..